Related references
Note: Only part of the references are listed.Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study
Hyeon-Cheol Gwon et al.
CIRCULATION (2012)
Very Late Stent Thrombosis and Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation Five-Year Outcome of the j-Cypher Registry
Takeshi Kimura et al.
CIRCULATION (2012)
Very Late Stent Thrombosis and Late Target Lesion Revascularization No End in Sight
David P. Faxon
CIRCULATION (2012)
Impact of the Everolimus-Eluting Stent on Stent Thrombosis A Meta-Analysis of 13 Randomized Trials
Usman Baber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents.
Seung-Jung Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study
Robert A. Byrne et al.
AMERICAN HEART JOURNAL (2009)
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
Herbert D. Aronow et al.
AMERICAN HEART JOURNAL (2009)
Temporal Relation Between Clopidogrel Cessation and Stent Thrombosis After Drug-Eluting Stent Implantation
Probal Roy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Effectiveness of Two-Year Clopidogrel plus Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
Gaetano Tanzilli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
Takeshi Kimura et al.
CIRCULATION (2009)
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Frederick G. Kushner et al.
CIRCULATION (2009)
Safety and Efficacy of Drug-Eluting and Bare Metal Stents Comprehensive Meta-Analysis of Randomized Trials and Observational Studies
Ajay J. Kirtane et al.
CIRCULATION (2009)
Twenty-Year Evolution of Percutaneous Coronary Intervention and Its Impact on Clinical Outcomes A Report From the National Heart, Lung, and Blood Institute-Sponsored, Multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries
Lakshmi Venkitachalam et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
Drug-Eluting Stent Thrombosis in Routine Clinical Practice Two-Year Outcomes and Predictors From the TAXUS ARRIVE Registries
John M. Lasala et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
Stent Thrombosis in Sweden A Report From the Swedish Coronary Angiography and Angioplasty Registry
Bo Lagerqvist et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
Stefanie Schulz et al.
EUROPEAN HEART JOURNAL (2009)
Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events
Ashna D. K. Bowry et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Effect of Prolonged Thienopyridine Use After Drug-Eluting Stent Implantation (from the TAXUS Landmark Trials Data)
Gregg W. Stone et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Stent Thrombosis, Clinical Events, and Influence of Prolonged Clopidogrel Use After Placement of Drug-Eluting Stent Data From an Observational Cohort Study of Drug-Eluting Versus Bare-Metal Stents
Duk-Woo Park et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2008)
Drug-eluting stent thrombosis -: Results from the Multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos)
Jos M. de la Torre-Hernandez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions
Somjot S. Brar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice -: 4-year results from a large 2-institutional cohort study
Peter Wenaweser et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
Flavio Airoldi et al.
CIRCULATION (2007)
Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal Stent coronary interventions
Lisette Okkels Jensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
Adnan Kastrati et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Stent thrombosis in randomized clinical trials of drug-eluting stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents
Christian Spaulding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents - A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians
Cindy L. Grines et al.
CIRCULATION (2007)
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
Eric L. Eisenstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents - An observational study of drug-eluting versus bare-metal stents
Matthias Pfisterer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials
Anthony A. Bavry et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement results from the PREMIER registry
John A. Spertus et al.
CIRCULATION (2006)
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents
PK Kuchulakanti et al.
CIRCULATION (2006)
Quality of ambulatory care for women and men in the veterans affairs health care system
AK Jha et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2005)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
I Iakovou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Share Paper
